carbamazepine has been researched along with methylphenidate in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (19.35) | 18.7374 |
| 1990's | 6 (19.35) | 18.2507 |
| 2000's | 9 (29.03) | 29.6817 |
| 2010's | 10 (32.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kutt, H | 1 |
| Oettinger, L | 1 |
| Crowner, S; Gourash, L; Rosenberg, DR; Thomas, C | 1 |
| Sheard, MH | 1 |
| Bow, J; Gershon, S; Lerer, B; Meyendorff, E; Moore, NC | 1 |
| Kutt, H; Penry, JK | 1 |
| Evans, RW; Gualtieri, CT | 1 |
| Gay, CT; Ryan, SG | 1 |
| Behar, D; Schaller, J; Spreat, S | 1 |
| Behar, D; Schaller, JL | 1 |
| Gross-Tsur, V | 1 |
| Elia, J; Rowan, A; Weller, EB; Weller, RA | 1 |
| Abbott, MB; Levin, RH | 1 |
| Hirabayashi, S; Koeda, T; Miyamoto, S; Sakakihara, Y | 1 |
| Chalvon, A; Durand, E; Habert, M; Landrieu, P; Navelet, Y; Portilla, P; Prigent, A | 1 |
| Bernat, C; Mathé, JF; Perrouin-Verbe, B; Richard, I; Rome, J | 1 |
| Hume, JH; Kowatch, RA; Kromelis, M; Sethuraman, G; Weinberg, WA | 1 |
| Cummings, MR; Miller, BD | 1 |
| Connolly, M; Dunn, DW; Gonzalez-Heydrich, J; Jan, JE; Kratochvil, CJ; Plioplys, S; Wambera, K; Weiss, M | 1 |
| Letzel, M; Schüssler, W; Sengl, M; Weiss, K | 1 |
| Niederhofer, H | 1 |
| Dempsey, M | 1 |
| Andreatini, R; Biojone, C; Casarotto, PC; Correia, D; Guimarães, FS; Joca, SL; Martynhak, BJ; Pereira, M; Siba, IP; Tonelli, DA | 1 |
10 review(s) available for carbamazepine and methylphenidate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pediatric psychopharmacology. A review with special reference to deanol.
Topics: Adolescent; Adult; Amphetamines; Animals; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Child, Preschool; Chlorpromazine; Deanol; Epilepsy; Ethanolamines; Heart Rate; Humans; Learning; Methylphenidate; Pemoline; Phenytoin; Rats; Syndrome; Thioridazine | 1977 |
Psychosis and idiopathic precocious puberty in two 7-year-old boys.
Topics: Attention Deficit Disorder with Hyperactivity; Body Height; Carbamazepine; Child; Developmental Disabilities; Humans; Lithium; Male; Methylphenidate; Psychiatric Status Rating Scales; Psychotic Disorders; Puberty, Precocious | 1992 |
Clinical pharmacology of aggressive behavior.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aggression; Carbamazepine; Central Nervous System Stimulants; Child; Child, Preschool; Female; Humans; Male; Methylphenidate; Tranquilizing Agents | 1988 |
Usefulness of blood levels of antiepileptic drugs.
Topics: Anticonvulsants; Carbamazepine; Chloramphenicol; Chlordiazepoxide; Chlorpromazine; Chromatography, Gas; Dextropropoxyphene; Diazepam; Dicumarol; Disulfiram; Drug Interactions; Epilepsy; Ethosuximide; Humans; Isoniazid; Methylphenidate; Phenethylamines; Phenobarbital; Phenylbutazone; Phenytoin; Primidone; Prochlorperazine; Sulfamethizole; Sulfaphenazole; Thiazines | 1974 |
Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
Topics: Adolescent; Aggression; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Child Development Disorders, Pervasive; Clinical Trials as Topic; Clomipramine; Clonidine; Conduct Disorder; Humans; Lithium; Methylphenidate; Psychotropic Drugs; Treatment Outcome | 1999 |
What's new: newly approved drugs for children.
Topics: Adolescent; Age Factors; Albuterol; Androstadienes; Anticonvulsants; Asthma; Atovaquone; Attention Deficit Disorder with Hyperactivity; Beclomethasone; Carbamazepine; Child; Delayed-Action Preparations; Diabetes Mellitus, Type 1; Drug Approval; Drug Combinations; Drug Delivery Systems; Drug Therapy; Epilepsies, Partial; Fluticasone-Salmeterol Drug Combination; HIV Protease Inhibitors; Humans; Insulin; Insulin Glargine; Insulin, Long-Acting; Lopinavir; Methylphenidate; Naphthoquinones; Nebulizers and Vaporizers; Oxcarbazepine; Pediatrics; Proguanil; Pyrimidinones; Ritonavir; United States | 2001 |
[ADHD and remedical intervention].
Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Carbamazepine; Child; Child, Preschool; Comorbidity; Counseling; Diagnosis, Differential; Environment; Humans; Methylphenidate; Selective Serotonin Reuptake Inhibitors | 2002 |
[Pharmacological treatment of post-traumatic behavioural disorders].
Topics: Adrenergic beta-Antagonists; Aggression; Anti-Anxiety Agents; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Brain Injuries; Carbamazepine; Central Nervous System Stimulants; Double-Blind Method; Humans; Lithium Compounds; Mental Disorders; Methylphenidate; Placebos; Prospective Studies; Psychomotor Agitation; Psychotropic Drugs; Randomized Controlled Trials as Topic; Retrospective Studies; Tranquilizing Agents | 2003 |
Pharmacologic management of behavioral instability in medically ill pediatric patients.
Topics: Adolescent; Adrenergic alpha-Agonists; Aggression; Analgesics, Non-Narcotic; Behavior Therapy; Behavioral Medicine; Benzodiazepines; Carbamazepine; Central Nervous System Stimulants; Child; Clonidine; Diphenhydramine; Histamine H1 Antagonists; Humans; Lithium; Methylphenidate; Psychomotor Agitation; Valproic Acid | 2004 |
2 trial(s) available for carbamazepine and methylphenidate
| Article | Year |
|---|---|
Carbamazepine and methylphenidate.
Topics: Anticonvulsants; Carbamazepine; Central Nervous System Stimulants; Child; Cross-Over Studies; Double-Blind Method; Drug Interactions; Humans; Methylphenidate | 1999 |
Combination pharmacotherapy in children and adolescents with bipolar disorder.
Topics: Adolescent; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Bupropion; Carbamazepine; Central Nervous System Stimulants; Child; Drug Therapy, Combination; Female; Humans; Lithium; Male; Methylphenidate; Prospective Studies; Risperidone; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 2003 |
19 other study(ies) available for carbamazepine and methylphenidate
| Article | Year |
|---|---|
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Interactions of antiepileptic drugs.
Topics: Anti-Infective Agents; Anticonvulsants; Benzodiazepines; Biotransformation; Blood Proteins; Carbamazepine; Dextropropoxyphene; Dicumarol; Disulfiram; Drug Interactions; Ethosuximide; Humans; Intestinal Absorption; Isoniazid; Methylphenidate; Phenethylamines; Phenobarbital; Phenothiazines; Phenytoin; Primidone; Protein Binding; Thiazines | 1975 |
Methylphenidate infusion in euthymic bipolars: effect of carbamazepine pretreatment.
Topics: Adult; Arousal; Bipolar Disorder; Carbamazepine; Euphoria; Female; Humans; Infusions, Parenteral; Male; Methylphenidate; Middle Aged; Premedication | 1985 |
Carbamazepine-induced tics.
Topics: Carbamazepine; Child; Dextroamphetamine; Humans; Male; Methylphenidate; Tic Disorders | 1984 |
Paroxysmal kinesigenic dystonia after methylphenidate administration.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Dystonia; Humans; Male; Methylphenidate | 1994 |
Extreme reduction of methylphenidate levels by carbamazepine.
Topics: Anticonvulsants; Carbamazepine; Central Nervous System Stimulants; Child; Drug Interactions; Humans; Liver; Male; Methylphenidate | 1998 |
Carbamazepine and methylphenidate in ADHD.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Humans; Methylphenidate; Weight Gain | 1999 |
[SPECT-identified hypoperfusion of the left temporomesial structures in a Kleine-Levin syndrome].
Topics: Adolescent; Carbamazepine; Dominance, Cerebral; Drug Therapy, Combination; Humans; Kleine-Levin Syndrome; Male; Methylphenidate; Periodicity; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 2002 |
Pharmacological management of a youth with ADHD and a seizure disorder.
Topics: Adrenergic Uptake Inhibitors; Anticonvulsants; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Central Nervous System Stimulants; Child; Epilepsy; Humans; Male; Methylphenidate; Propylamines | 2006 |
Occurrence and fate of the human pharmaceutical metabolite ritalinic acid in the aquatic system.
Topics: Carbamazepine; Central Nervous System Stimulants; Environmental Monitoring; Fresh Water; Methylphenidate; Models, Chemical; Waste Disposal, Fluid | 2010 |
Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine.
Topics: Aggression; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Cholinesterase Inhibitors; Drug Synergism; Humans; Male; Methylphenidate; Propylamines; Time Factors; Treatment Outcome | 2011 |
A true mystery diagnosis.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Central Nervous System Stimulants; Confusion; Diagnosis, Differential; Disorders of Excessive Somnolence; Humans; Hyperphagia; Hypnotics and Sedatives; Kleine-Levin Syndrome; Lorazepam; Male; Methylphenidate; Oxcarbazepine | 2011 |
The antimanic-like effect of phenytoin and carbamazepine on methylphenidate-induced hyperlocomotion: role of voltage-gated sodium channels.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Carbamazepine; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Methylphenidate; Mice; Motor Activity; Phenytoin; Veratrine; Voltage-Gated Sodium Channels | 2013 |